165 related articles for article (PubMed ID: 10607766)
1. Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group.
Koch JA; Plum J; Grabensee B; Mödder U
Nephrol Dial Transplant; 2000 Jan; 15(1):43-9. PubMed ID: 10607766
[TBL] [Abstract][Full Text] [Related]
2. [Prostaglandin E1 for prevention of contrast medium-induced kidney dysfunction].
Koch JA; Sketch M; Brinker J; Bernink PJ
Rofo; 1999 Jun; 170(6):557-63. PubMed ID: 10420905
[TBL] [Abstract][Full Text] [Related]
3. Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study.
Sketch MH; Whelton A; Schollmayer E; Koch JA; Bernink PJ; Woltering F; Brinker J;
Am J Ther; 2001; 8(3):155-62. PubMed ID: 11344383
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.
Kurnik BR; Allgren RL; Genter FC; Solomon RJ; Bates ER; Weisberg LS
Am J Kidney Dis; 1998 Apr; 31(4):674-80. PubMed ID: 9531185
[TBL] [Abstract][Full Text] [Related]
5. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E
J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558
[TBL] [Abstract][Full Text] [Related]
6. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
Rashid ST; Salman M; Myint F; Baker DM; Agarwal S; Sweny P; Hamilton G
J Vasc Surg; 2004 Dec; 40(6):1136-41. PubMed ID: 15622367
[TBL] [Abstract][Full Text] [Related]
7. Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.
Li WH; Li DY; Qian WH; Liu JL; Xu TD; Zhu H; He HY
Int Urol Nephrol; 2014 Apr; 46(4):781-6. PubMed ID: 24570327
[TBL] [Abstract][Full Text] [Related]
8. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
[TBL] [Abstract][Full Text] [Related]
9. Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline.
Erley CM; Duda SH; Rehfuss D; Scholtes B; Bock J; Müller C; Osswald H; Risler T
Nephrol Dial Transplant; 1999 May; 14(5):1146-9. PubMed ID: 10344353
[TBL] [Abstract][Full Text] [Related]
10. Analysis of radiocontrast-induced nephropathy by dual-labeled radionuclide clearance.
Albert SG; Shapiro MJ; Brown WW; Goodgold H; Zuckerman D; Durham R; Kern M; Fletcher J; Wolverson M; Plummer ES
Invest Radiol; 1994 Jun; 29(6):618-23. PubMed ID: 8088970
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.
Vogt B; Ferrari P; Schönholzer C; Marti HP; Mohaupt M; Wiederkehr M; Cereghetti C; Serra A; Huynh-Do U; Uehlinger D; Frey FJ
Am J Med; 2001 Dec; 111(9):692-8. PubMed ID: 11747848
[TBL] [Abstract][Full Text] [Related]
12. Effects of an acute dose of L-arginine during coronary angiography in patients with chronic renal failure: a randomized, parallel, double-blind clinical trial.
Miller HI; Dascalu A; Rassin TA; Wollman Y; Chernichowsky T; Iaina A
Am J Nephrol; 2003; 23(2):91-5. PubMed ID: 12481147
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
14. Relationship of proximal fixation to renal dysfunction in patients undergoing endovascular aneurysm repair.
Mehta M; Cayne N; Veith FJ; Darling RC; Roddy SP; Paty PS; Ozsvath KJ; Kreienberg PB; Chang BB; Shah DM
J Cardiovasc Surg (Torino); 2004 Aug; 45(4):367-74. PubMed ID: 15365517
[TBL] [Abstract][Full Text] [Related]
15. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans.
Weisberg LS; Kurnik PB; Kurnik BR
Ren Fail; 1993; 15(1):61-8. PubMed ID: 8441838
[TBL] [Abstract][Full Text] [Related]
16. Protection from the nephrotoxicity of contrast dye.
Louis BM; Hoch BS; Hernandez C; Namboodiri N; Neiderman G; Nissenbaum A; Foti FP; Magno A; Banayat G; Fata F; Manohar NL; Lipner HI
Ren Fail; 1996 Jul; 18(4):639-46. PubMed ID: 8875691
[TBL] [Abstract][Full Text] [Related]
17. Alprostadil plays a protective role in contrast-induced nephropathy in the elderly.
Miao Y; Zhong Y; Yan H; Li W; Wang BY; Jin J
Int Urol Nephrol; 2013 Aug; 45(4):1179-85. PubMed ID: 23860961
[TBL] [Abstract][Full Text] [Related]
18. Radiocontrast nephropathy: is it dose related or not?
Mekan SF; Rabbani MA; Azhar-uddin M; Ali SS
J Pak Med Assoc; 2004 Jul; 54(7):372-4. PubMed ID: 15449920
[TBL] [Abstract][Full Text] [Related]
19. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
Brar SS; Aharonian V; Mansukhani P; Moore N; Shen AY; Jorgensen M; Dua A; Short L; Kane K
Lancet; 2014 May; 383(9931):1814-23. PubMed ID: 24856027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
